Table 1 Nanoparticles against different cancer types

AgNPs

44.04 to 66.5

 − 55.3

Breast, Colon

[5, 6]

AuNPs

14 ± 4

 − 18 mV

Breast

[150]

AuNPs

49.8 ± 6.6

− 11.3

Breast

[151]

Liposomes

244.3 ± 16.7

22.9 ± 1.7

Lung, Ovarian

[152]

HSA

143.4 ± 0.7

− 5.6 ± 0.8

Breast

[153]

PTX-HAS

170.2 ± 1.4

− 17.4 ± 0.5

Breast

[153]

NHA

50.3 ± 6.2

 − 21.5 ± 2.7

Breast

[154]

PLGA

210

27

Lung

[155]

PLGA

330 ± 3

− 3.9 ± 03

Colon

[155]

PLGA

204

− 5.6

Liver

[155]

PLGA

240 ± 1

− 19.5

Ovarian

[155]

SEB

389.7 ± 16.49

 − 13.5 ± 12.1

Lung, Breast

[156]

PLGA-PEG-HA

265.6 ± 3.8

− 30.4 ± 0.1

Ovarian

[157]

PLGA

429.26 ± 41.53

− 11.2

Liver

[158]

LTZ-PLGA

64.0 ± 15.4

− 25.0 ± 0.4

Breast

[159]

PEG-PLA

140 ± 15

− 14 ± 4

Prostate

[129]

PEG-PLGA

114–335

 − 2.8 to − 26.2

Breast

[130]

HA-GEM/CH-Pt

187

− 21

Lung

[160]

HA-CS

210

 + 25

Breast

[161]

POM-CS

105 ± 6

 + 52.0 ± 5.2

Cervical

[162]

MNP-GEM-PTX

152 ± 4

− 4.15 ± 1

Pancreatic

[163]